Cargando…
A gain of function paradox: Targeted therapy for glioblastoma associated with abnormal NHE9 expression
Glioblastoma (GBM) is the most frequent and inevitably lethal primary brain cancer in adults. It is recognized that the overexpression of the endosomal Na(+)/H(+) exchanger NHE9 is a potent driver of GBM progression. Patients with NHE9 overexpression have a threefold lower median survival relative t...
Autores principales: | Pall, Ashley E., Juratli, Lena, Guntur, Dhyana, Bandyopadhyay, Krisanu, Kondapalli, Kalyan C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6815843/ https://www.ncbi.nlm.nih.gov/pubmed/31532058 http://dx.doi.org/10.1111/jcmm.14665 |
Ejemplares similares
-
MicroRNA-135a regulates NHE9 to inhibit proliferation and migration of glioblastoma cells
por: Gomez Zubieta, Daniela M., et al.
Publicado: (2017) -
FUNCTIONAL EVALUATION OF AUTISM-ASSOCIATED MUTATIONS IN NHE9
por: Kondapalli, Kalyan C., et al.
Publicado: (2013) -
The sodium proton exchanger NHE9 regulates phagosome maturation and bactericidal activity in macrophages
por: Shamroukh, Habiba S., et al.
Publicado: (2022) -
The endosomal pH regulator NHE9 is a driver of stemness in glioblastoma
por: Ko, Myungjun, et al.
Publicado: (2022) -
Genes for endosomal NHE6 and NHE9 are misregulated in autism brains
por: Schwede, M, et al.
Publicado: (2014)